Description
RNA-seq data of candidate drug treatments of a CRISPR-engineered cell line carrying an infant-AML t(7;12) chromosomal translocation.
| Date made available | 12 Sept 2025 |
|---|---|
| Publisher | ArrayExpress, BioStudies, EMBL-EBI |
Research output
- 1 Other contribution
-
Integrated in silico and in vitro approaches identify SNX.2112 as a drug vulnerability in t(7;12) AML stem-like cells
Cicirò, Y., Ragusa, D., Johnson, E., Johns, A., Kanannejad, S., Gurung, R., Oporto Espuelas, M., Suen, C.-W., Torregrosa Cortes, G., Giustacchini, A., Tosi, S. & Pina, C., 11 Sept 2025Research output: Other contribution › Academic
Open Access
Cite this
- DataSetCite